Stock listing

Ascendis Pharma A/s

Selected listing: A710 · MUN · EUR · DE

Ascendis Pharma A/s (Munich:A710), Health Technology. Latest release Oct 6, 2026: Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia…

A710:MUNEURDEUpdated October 3, 2026

Ticker: Munich:A710
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Ascendis Pharma A/s

Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026

October 6, 2026

Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026

October 5, 2026

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

September 14, 2026

Ascendis Announces Planned $400 Million Share Repurchase Program

September 14, 2026

First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026

September 9, 2026

All Ascendis Pharma A/s news →

Events

Replays

Ascendis Pharma A/S (ASND) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 08:00 AM ET
Watch
Ascendis Pharma A/S (ASND) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:00 AM ET
Watch
Ascendis Pharma A/S (ASND) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 04:30 PM ET
Watch

Research Ascendis Pharma A/s

Ascendis Pharma A/s company profile

View the public company page for Ascendis Pharma A/s on 6ix.

Ascendis Pharma A/s news

Read company news and market updates connected to Ascendis Pharma A/s.

Ascendis Pharma A/s investor events

Find investor webinars, events, and replay context for Ascendis Pharma A/s.